Latest

Atea Announces Publication of Data Highlighting AT-752’s Potent Activity Against Dengue and Other Flaviviruses

CalciMedica Publishes Positive Data from Phase 2a Study of Auxora in Patients with Acute Pancreatitis and Announces First Patients

OncoResponse Raises $40.6 Million Series C Financing

Targeting a Key Marker of Clotting and Inflammation in COVID-19 Patients

Targeting Calcium Overload Could Improve Stroke Outcomes

COVID-19 viral biotech Atea Pharmaceuticals prices upsized IPO at $24 high end